• 中國(guó)醫(yī)學(xué)科學(xué)院,中國(guó)協(xié)和醫(yī)科大學(xué),北京協(xié)和醫(yī)院基本外科(北京100730);

目的  通過WST-8和膠原凝膠微滴腫瘤藥物敏感性檢測(cè)(CD-DST) 2種藥敏檢測(cè)方法的比較,對(duì)CD-DST法進(jìn)行評(píng)價(jià)。方法  以胰腺癌細(xì)胞系SW1990、PCT-3和ASPC-1為對(duì)象,分別采用WST-8和CD-DST法測(cè)定其對(duì)5-氟尿嘧啶(5-FU)、健擇(GEM)和奧沙利鉑(OXA)3種藥物的敏感性。結(jié)果  在一定的活細(xì)胞數(shù)目范圍內(nèi)(500~10 000個(gè)),CD-DST法所測(cè)得的細(xì)胞積分光密度與細(xì)胞數(shù)目成線性正相關(guān)(r=0.991 1, P<0.05); 3種腫瘤細(xì)胞的生長(zhǎng)抑制率CD-DST法均高于WST-8法(P<0.05),2種方法測(cè)定的5-FU、GEM和OXA藥物敏感性結(jié)果一致。結(jié)論  CD-DST法可用于胰腺癌的體外藥敏檢測(cè),具有一定的臨床應(yīng)用價(jià)值。

引用本文: 周濤,胡亞,廖泉,趙玉沛. 2種體外腫瘤細(xì)胞藥敏檢測(cè)方法的比較研究. 中國(guó)普外基礎(chǔ)與臨床雜志, 2008, 15(11): 825-828. doi: 復(fù)制

1. Yasuda H, Takada T, Wada K, et al. A new in-vitro drug sensitivity test (collagen-gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility [J]. J Hepatobiliary Pancreat Surg, 1998; 5(3)∶261.
2. 廖 泉, 趙玉沛, 蔡力行, 等. 胰腺癌細(xì)胞對(duì)化療藥物敏感性的測(cè)定 [J]. 中華實(shí)驗(yàn)外科雜志, 1998; 15(5)∶ 444.
3. Kobayashi H, Higashiyama M, Minamigawa K, et al. Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification [J]. Jpn J Cancer Res, 2001; 92(2)∶203.
4. Alley MC, Scudiero DA, Monks A, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay [J]. Cancer Res, 1988; 48(3)∶589.
5. Yang J, Richards J, Bowman P, et al. Sustained growth and three-dimensional organization of primary mammary tumor epithelial cells embedded in collagen gels [J]. Proc Natl Acad Sci USA, 1979; 76(7)∶3401.
6. Richards J, Larson L, Yang J, et al. Method for culturing mammary epithelial cells in a rat tail collagen gel matrix [J]. Methods Cell Sci, 1983; 8(1)∶ 31.
7. Kawamura M, Gika M, Abiko T, et al. Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST) [J]. Cancer Chemother Pharmacol, 2007; 59(4)∶507.
8. Vaccarello L, Wang YL, Whiteside TL. Sustained outgrowth of autotumor-reactive T lymphocytes from human ovarian carcinomas in the presence of tumor necrosis factor alpha and interleukin 2 [J]. Hum Immunol, 1990; 28(2)∶216.
9. Sieuwerts AM, Klijn JG, Peters HA, et al. The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival [J]. Eur J Clin Chem Clin Biochem, 1995; 33(11)∶813.
10. Fricker SP, Buckley RG. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents [J]. Anticancer Res, 1996; 16(6B)∶3755.
11. Chen CF, Hwang JM, Wu CH, et al. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs [J]. Zhonghua Yi Xue Za Zhi (Taipei), 1990; 46(1)∶7.
  1. 1. Yasuda H, Takada T, Wada K, et al. A new in-vitro drug sensitivity test (collagen-gel droplet embedded-culture drug sensitivity test) in carcinomas of pancreas and biliary tract: possible clinical utility [J]. J Hepatobiliary Pancreat Surg, 1998; 5(3)∶261.
  2. 2. 廖 泉, 趙玉沛, 蔡力行, 等. 胰腺癌細(xì)胞對(duì)化療藥物敏感性的測(cè)定 [J]. 中華實(shí)驗(yàn)外科雜志, 1998; 15(5)∶ 444.
  3. 3. Kobayashi H, Higashiyama M, Minamigawa K, et al. Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification [J]. Jpn J Cancer Res, 2001; 92(2)∶203.
  4. 4. Alley MC, Scudiero DA, Monks A, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay [J]. Cancer Res, 1988; 48(3)∶589.
  5. 5. Yang J, Richards J, Bowman P, et al. Sustained growth and three-dimensional organization of primary mammary tumor epithelial cells embedded in collagen gels [J]. Proc Natl Acad Sci USA, 1979; 76(7)∶3401.
  6. 6. Richards J, Larson L, Yang J, et al. Method for culturing mammary epithelial cells in a rat tail collagen gel matrix [J]. Methods Cell Sci, 1983; 8(1)∶ 31.
  7. 7. Kawamura M, Gika M, Abiko T, et al. Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST) [J]. Cancer Chemother Pharmacol, 2007; 59(4)∶507.
  8. 8. Vaccarello L, Wang YL, Whiteside TL. Sustained outgrowth of autotumor-reactive T lymphocytes from human ovarian carcinomas in the presence of tumor necrosis factor alpha and interleukin 2 [J]. Hum Immunol, 1990; 28(2)∶216.
  9. 9. Sieuwerts AM, Klijn JG, Peters HA, et al. The MTT tetrazolium salt assay scrutinized: how to use this assay reliably to measure metabolic activity of cell cultures in vitro for the assessment of growth characteristics, IC50-values and cell survival [J]. Eur J Clin Chem Clin Biochem, 1995; 33(11)∶813.
  10. 10. Fricker SP, Buckley RG. Comparison of two colorimetric assays as cytotoxicity endpoints for an in vitro screen for antitumour agents [J]. Anticancer Res, 1996; 16(6B)∶3755.
  11. 11. Chen CF, Hwang JM, Wu CH, et al. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs [J]. Zhonghua Yi Xue Za Zhi (Taipei), 1990; 46(1)∶7.